Evidence (1902 claims)
Adoption
5126 claims
Productivity
4409 claims
Governance
4049 claims
Human-AI Collaboration
2954 claims
Labor Markets
2432 claims
Org Design
2273 claims
Innovation
2215 claims
Skills & Training
1902 claims
Inequality
1286 claims
Evidence Matrix
Claim counts by outcome category and direction of finding.
| Outcome | Positive | Negative | Mixed | Null | Total |
|---|---|---|---|---|---|
| Other | 369 | 105 | 58 | 432 | 972 |
| Governance & Regulation | 365 | 171 | 113 | 54 | 713 |
| Research Productivity | 229 | 95 | 33 | 294 | 655 |
| Organizational Efficiency | 354 | 82 | 58 | 34 | 531 |
| Technology Adoption Rate | 277 | 115 | 63 | 27 | 486 |
| Firm Productivity | 273 | 33 | 68 | 10 | 389 |
| AI Safety & Ethics | 112 | 177 | 43 | 24 | 358 |
| Output Quality | 228 | 61 | 23 | 25 | 337 |
| Market Structure | 105 | 118 | 81 | 14 | 323 |
| Decision Quality | 154 | 68 | 33 | 17 | 275 |
| Employment Level | 68 | 32 | 74 | 8 | 184 |
| Fiscal & Macroeconomic | 74 | 52 | 32 | 21 | 183 |
| Skill Acquisition | 85 | 31 | 38 | 9 | 163 |
| Firm Revenue | 96 | 30 | 22 | — | 148 |
| Innovation Output | 100 | 11 | 20 | 11 | 143 |
| Consumer Welfare | 66 | 29 | 35 | 7 | 137 |
| Regulatory Compliance | 51 | 61 | 13 | 3 | 128 |
| Inequality Measures | 24 | 66 | 31 | 4 | 125 |
| Task Allocation | 64 | 6 | 28 | 6 | 104 |
| Error Rate | 42 | 47 | 6 | — | 95 |
| Training Effectiveness | 55 | 12 | 10 | 16 | 93 |
| Worker Satisfaction | 42 | 32 | 11 | 6 | 91 |
| Task Completion Time | 71 | 5 | 3 | 1 | 80 |
| Wages & Compensation | 38 | 13 | 19 | 4 | 74 |
| Team Performance | 41 | 8 | 15 | 7 | 72 |
| Hiring & Recruitment | 39 | 4 | 6 | 3 | 52 |
| Automation Exposure | 17 | 15 | 9 | 5 | 46 |
| Job Displacement | 5 | 28 | 12 | — | 45 |
| Social Protection | 18 | 8 | 6 | 1 | 33 |
| Developer Productivity | 25 | 1 | 2 | 1 | 29 |
| Worker Turnover | 10 | 12 | — | 3 | 25 |
| Creative Output | 15 | 5 | 3 | 1 | 24 |
| Skill Obsolescence | 3 | 18 | 2 | — | 23 |
| Labor Share of Income | 7 | 4 | 9 | — | 20 |
Skills Training
Remove filter
Policies that incentivize interoperable, privacy-preserving data sharing (e.g., federated data, common standards) can reduce entry barriers and improve social returns from AI in drug R&D.
Policy analysis and recommendations from the review, supported by conceptual arguments and examples of federated/privacy-preserving platforms; limited empirical validation of large-scale impact.
AI has the potential to raise R&D productivity by shortening timelines and reducing certain failure modes, thereby increasing the net present value (NPV) of successful drug projects.
Economic reasoning and projections based on documented process improvements in the reviewed studies and reports; not validated by longitudinal, generalized financial analyses in the literature.
AI enhances post-market safety signal detection using real-world data analytics.
Industry and regulatory reports and published studies in the review documenting improved detection or earlier identification of safety signals in pharmacovigilance applications using ML on real-world datasets.
AI-enabled adaptive and enrichment trial designs increase trial efficiency and statistical power.
Methodological studies, clinical-trial case studies, and regulatory guidance summarized in the review showing applications of ML to adaptive/enrichment designs; evidence mainly illustrative and context-specific.
AI improves predictive toxicity and ADMET models, which can reduce late-stage failures.
Multiple empirical studies and industry case reports aggregated in the narrative review demonstrating improved in silico toxicity/ADMET prediction performance in specific settings; heterogeneity across datasets and endpoints; not a formal meta-analysis.
AI can reduce time-to-market and lower some drug development costs.
Synthesis of case studies, industry reports, and empirical studies reported in the narrative review that document examples of compressed timelines and cost savings in parts of the pipeline; review notes lack of long-run, generalized ROI estimates.
AI is materially accelerating discovery and development steps in pharmaceutical R&D, improving target identification, lead optimization, safety prediction, and adaptive trial design.
Narrative review synthesizing published studies, review articles, industry and regulatory reports; evidence primarily consists of empirical studies and case studies covering preclinical and clinical-stage applications. No pooled quantitative meta-analysis; heterogeneous methods and therapeutic areas.
Firms with superior proprietary data and integration capability gain competitive advantage, increasing firm-level heterogeneity in AI returns.
Narrative analysis of market structure implications and examples; no cross-firm empirical heterogeneity study included.
Returns to complementary investments (data infrastructure, experiment automation, cross-disciplinary teams) increase as AI becomes more central to discovery workflows.
Synthesis of adoption lessons and case examples emphasizing complementary capital; no quantitative ROI estimates provided.
Embedding AI into organizational processes, decision-making, and wet-lab validation is crucial to capturing its value.
Narrative review of adoption and integration lessons from large biopharma experience and illustrative case studies.
Successful AI adoption requires investment in data, talent, and workflows rather than reliance on bolt-on point solutions.
Thematic analysis of adoption-level lessons and industry case examples indicating organizational and infrastructural requirements for realized value.
AI has produced genuine early-stage breakthroughs in drug discovery, accelerating hit identification and early design cycles.
Narrative expert synthesis and thematic analysis of industry experience over the first decade of AI adoption, illustrated by early-case successes and firm-reported accelerations; no new primary experimental data or causal econometric estimates provided.
Public policies that lower frictions for secure data sharing, standardize validation metrics, and support workforce retraining can accelerate beneficial diffusion of AI while managing risks.
Policy recommendation based on the paper's synthesis of enablers and constraints; not empirically tested within the paper.
AI has the potential to reduce marginal cost and time per candidate (shorter design loops, in silico screening), increasing effective productivity of R&D spend if improvements are validated.
Theoretical and conceptual argument referencing capabilities of generative models and simulation; paper states no new quantitative estimates were produced.
Workforce upskilling and new roles (e.g., ML engineers embedded in biology teams, AI product managers) are required for effective AI integration in pharma R&D.
Descriptive projection based on observed industry hiring trends and organizational needs; no workforce survey data provided.
Cloud/federated approaches reduce upfront infrastructure investments and facilitate distributed collaboration.
Conceptual argument based on cloud economics and federated architectures; no quantitative cost-savings or collaboration metrics presented.
Cloud and federated approaches enable access to powerful pre-trained or fine-tunable models while allowing proprietary data to remain controlled (privacy-preserving sharing and model-to-data patterns).
Technological synthesis and examples of federated learning and cloud-hosted ML patterns; no empirical performance or privacy-utility tradeoff measurements reported.
Startups can leverage pre-trained models, cloud compute, and hosted toolchains to compete on speed and niche innovation against larger incumbents.
Conceptual observation and illustrative examples; not supported by systematic comparison of startup vs incumbent performance metrics in the paper.
AI lowers entry costs for smaller biotech by enabling faster molecular design, simulation, and iteration, allowing earlier translation to clinical stages.
Argument grounded in current capabilities (pre-trained models, cloud compute) and illustrative startup examples; no empirical cost or time-to-clinic data provided.
Production-first democratization builds user-friendly, productionized AI tools that non-specialists can use, decentralizing model use and accelerating throughput.
Narrative examples and conceptual reasoning in the editorial; lacks systematic evaluation of throughput gains or decentralization effects.
Culture-centric transformation embeds AI into everyday scientific and operational decisions and requires organizational change, incentives, and cross-functional workflows.
Conceptual argument and organizational theory applied in the editorial; no empirical measurement of organizational change or success rates provided.
Partnership-driven acceleration lets pharma access AI capabilities rapidly via alliances with AI/tech firms while allowing pharma to preserve focus on core drug expertise and outsource model or platform development.
Qualitative description and illustrative examples in the editorial; not supported by systematic case study data or quantified outcomes.
Regulators should anticipate new forms of intangible capital and data monopolies arising from sensory models and consider standards for data interoperability, public datasets/models, and workforce retraining.
Policy recommendation based on foresight and literature on data governance and platform regulation; no empirical regulatory impact analysis provided.
Economics of AI in food must incorporate non-price metrics (perceptual quality, cultural fit) and design ways to monetize and protect sensory intellectual property (trade secrets, data governance).
Normative policy and methodological recommendation derived from literature synthesis and conceptual analysis; not validated with empirical economic valuation studies.
Interdisciplinary approaches (cognitive science, behavioral economics, design thinking) are necessary to capture the social, perceptual, and cultural dimensions of food experience.
Normative argument supported by literature synthesis across relevant disciplines; no experimental comparison of mono- vs interdisciplinary approaches provided.
Treating food as a soft-matter system centered on rheology provides a bridge from molecular/structural properties to macroscopic sensory experience.
Conceptual and theoretical argument grounded in soft-matter science and rheology literature; interdisciplinary literature synthesis; no new empirical data or experiments reported.
The study discovers a three-dimensional model for measuring performance, including AI Tool Mastery, Collaborative Work Quality, and Human-AI Synergy to measure hybrid skills developed through human-machine collaboration.
Model development derived from systematic analysis of the collected data (5,000 LinkedIn job adverts and 2,000 Indeed salary records, 2022–2024) and theorizing about dimensions needed to capture hybrid human-AI skills; the paper reports these three dimensions as its measurement model.
AI-trained staff are rewarded with a 17.7% overall premium for their wages.
Analysis of 2,000 Indeed salary data records from 2022–2024, comparing salaries for roles or incumbents identified as having AI training/skills versus those without.
The need for AI skills has grown at a rate of 376% since the release of ChatGPT.
Temporal comparison within the dataset of LinkedIn job adverts from 2022–2024 (5,000 adverts), comparing pre- and post-ChatGPT frequencies of AI-skill mentions to compute growth rate.
AI skills are especially needed in 27.8% of knowledge workers' jobs.
Systematic analysis of 5,000 LinkedIn job adverts collected between 2022–2024, where job postings were coded for AI-skill requirements, yielding the reported percentage.
Dynamic feedback loops create reinforcing organisational learning cycles.
Theoretical assertion from the paper's synthesis indicating learning dynamics as part of the model; described conceptually without empirical quantification in the abstract.
Complementarity–trust interaction determines optimal performance when high capability utilisation combines with appropriate trust levels.
Mechanistic claim from the TCM‑CI derived via systematic review/synthesis of existing studies; no primary experimental or field sample reported in the abstract to validate this interaction effect.
Calibrated trust maximises collective intelligence by balancing appropriate reliance with necessary oversight.
Core mechanism asserted by the paper based on synthesis of prior research in human–AI interaction and trust literature; presented as a conceptual mechanism rather than tested empirically in the abstract.
The Trust–Complementarity Model of Collective Intelligence (TCM‑CI) explains how calibrated trust and complementary capability utilisation drive superior organisational performance.
Theoretical model proposed by the authors derived from systematic literature synthesis (conceptual/modeling contribution); abstract does not report empirical validation or sample size.
Digital skills have surpassed traditional educational attainment to become a core human-capital element determining labor market performance in South Korea.
Interpretation based on regression results from the extended Mincerian wage equation applied to KLIPS micro-data showing sizable and significant wage premiums for digital skills even after controlling for years of education and other covariates.
For graduates of Technical and Vocational Education and Training (TVET), acquiring advanced digital skills significantly narrows the income gap with general higher education graduates.
Heterogeneity analysis on KLIPS micro-data examining interaction of educational pathway (TVET vs general higher education) with possession of advanced digital skills in extended Mincerian wage regressions; the result reported is a significant narrowing of the earnings gap (no numeric magnitude given in the excerpt).
AI-powered developer tools (often based on large language models) aim to automate routine tasks and make secure software development more accessible and efficient.
Framing/assumption in the paper's introduction (general description of such tools' intended purpose; not directly measured in this experiment).
Organizations increasingly adopt AI-powered development tools to boost productivity and reduce reliance on limited human expertise, especially in security-critical software development.
Background/contextual claim stated in the paper to motivate the study (general trend claim; likely supported by prior literature but not by the study's experimental data described here).
Both stable individual differences and moment-to-moment fluctuations in perspective-taking influence AI response quality.
Analyses reported in the paper linking both trait-level (stable) and state-level (moment-to-moment) measures of perspective-taking to variation in AI response quality across the benchmark dataset; assessed via the Bayesian IRT model and supplementary within-subject analyses.
Theory of Mind (the capacity to infer and adapt to others' mental states) emerges as a key predictor of synergy.
Statistical association reported between participants' Theory of Mind measures and the estimated synergy (improvement in performance with AI), based on analysis of the benchmark dataset (n = 667) within the Bayesian IRT framework.
Sustainable human capital development requires coordinated interaction between education systems, employers, and public institutions.
Normative recommendation derived from the paper's systemic analysis and comparative review of institutional responses; no empirical policy evaluation or quantified cross-country causal analysis reported.
Alignment of educational strategies with labor market dynamics is necessary to support effective reskilling and upskilling.
Supported by comparative assessment of international practices and systemic analysis linking education strategies to labor market requirements; evidence is analytical rather than experimental or longitudinally quantified in the paper.
Effective reskilling and upskilling depend on the development of continuous learning ecosystems.
Analytical conclusion drawn from organizational learning models and international practice comparison; no controlled trials or quantitative evaluation of specific ecosystems reported.
As technological change accelerates, the ability of individuals and organizations to adapt becomes a central condition of economic resilience and long-term competitiveness.
Analytical generalization from organizational learning models and systemic analysis of labor-market dynamics; supported by comparative observations but not by a reported empirical causal study.
The study recommends multi-stakeholder collaborations (policymakers, financial institutions, entrepreneurs) to design inclusive AI solutions, bridge the digital skills gap, and foster an environment for equitable entrepreneurial growth.
Policy and practice recommendations drawn in the paper's conclusion based on empirical findings and interpretation of barriers.
Firms with high AI adoption reported superior decision-making quality compared to low adopters.
Survey comparisons of decision-making quality measures between AI adoption groups in the questionnaire data (N=400), reported as superior for high adopters.
Firms with high AI adoption reported significantly higher financial literacy scores compared to low adopters.
Comparison of financial literacy scores between high and low AI adoption groups derived from the structured questionnaire responses (sample N=400); described as 'significantly higher' in the paper.
There is a positive correlation between the level of AI adoption and key business outcomes.
Survey-based correlational analysis reported in the paper linking self-reported AI adoption level to business outcome measures across the sample of 400 respondents.
New employment opportunities are emerging in AI-complementary occupations.
Findings from job-posting analyses and other empirical studies summarized in the paper that identify growth in AI-complementary job listings and roles (specific metrics not provided in excerpt).
Generative AI (GenAI), particularly tools such as ChatGPT and Gemini, has rapidly transformed the global technological landscape.
Qualitative/observational statement in paper citing the rapid public adoption of GenAI tools since late 2022; no specific empirical sample sizes reported in the text provided.